Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Cell Endocrinol. 2002 Jul 31;193(1-2):65-9.

Variant estrogen receptors and their role in liver disease.

Author information

1
Department of Internal Medicine, Chair of Gastroenterology, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. villa.erica@unimo.it

Abstract

The liver presents estrogen receptors alpha and beta. As for breast cancer, a variant form of estrogen receptor alpha transcript (ER) has been described in hepatocellular carcinoma (HCC). It is derived by an exon 5-deleted transcript (vER), which lacks the hormone-binding domain of the receptor but, being intact in the DNA-binding domain, maintains constitutive transcriptional activity. HCCs presenting vER have an extremely aggressive clinical course and are unresponsive to the antiestrogen tamoxifen. On the other hand, megestrol, a drug able to block both the wild type and the variant form of ER, influence the clinical course of HCC presenting vER. The presence of vER is associated with elevated cancer cell proliferation rate.

PMID:
12161003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center